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Vibrio harveyi is one of the major pathogens of aquatic organisms, affecting both verte-
brates and invertebrates, and causes important losses in the aquaculture industry. In order
to develop novel methods to control disease caused by this pathogen, we need to obtain a
better understanding of pathogenicity mechanisms. Sensing of catecholamines increases
both growth and production of virulence-related factors in pathogens of terrestrial animals
and humans. However, at this moment, knowledge on the impact of catecholamines on
the virulence of pathogens of aquatic organisms is lacking. In the present study, we report
that in V. harveyi, norepinephrine (NE) and dopamine (Dopa) increased growth in serum-
supplemented medium, siderophore production, swimming motility, and expression of
genes involved in ﬂagellar motility, bioﬁlm formation, and exopolysaccharide production.
Consistent with this, pretreatment of V. harveyi with catecholamines prior to inoculation
into the rearingwater resulted in signiﬁcantly decreased survival of gnotobiotic brine shrimp
larvae, when compared to larvae challenged with untreatedV. harveyi. Further, NE-induced
effects could be neutralized by α-adrenergic antagonists or by the bacterial catecholamine
receptor antagonist LED209, but not by β-adrenergic or dopaminergic antagonists. Dopa-
induced effects could be neutralized by dopaminergic antagonists or LED209, but not by
adrenergic antagonists.Together, our results indicate that catecholamine sensing increases
the success of transmission of V. harveyi and that interfering with catecholamine sensing
might be an interesting strategy to control vibriosis in aquaculture. We hypothesize that
upon tissue and/or hemocyte damage during infection, pathogens come into contact with
elevated catecholamine levels, and that this stimulates the expression of virulence factors
that are required to colonize a new host.
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INTRODUCTION
Vibrio harveyi is a ubiquitous, bioluminescent marine bacterium
which can cause luminous vibriosis in both marine vertebrates
and invertebrates, leading to signiﬁcant losses in the global
aquaculture industry (Austin and Zhang, 2006; Ruwandeepika
et al., 2012). For example, it has been reported to be associ-
ated with high mortalities of cultured penaeid shrimp larvae
and packhorse rock lobster larvae (Soto-Rodriguez et al., 2003),
diseased sea horses (Tendencia, 2004), and skin ulceration in
juvenile sea cucumber (Becket et al., 2004). The pathogenic-
ity of V. harveyi is considered to involve bioﬁlm formation,
swimming motility, and the production of various extracellu-
lar products, such as hemolysins, proteases, (phospho)lipases,
and chitinases (Karunasagar et al., 1994; Austin and Zhang,
2006; Ruwandeepika et al., 2012; Yang and Defoirdt, 2014). Con-
ventional antibiotics are becoming increasingly ineffective to
control bacterial infections in aquaculture, and consequently,
alternative methods to control infections are urgently needed
(Defoirdt et al., 2011). In this respect, inhibiting the produc-
tion of virulence-related phenotypes, a strategy that has been
termed antivirulence therapy, is an interesting novel approach
for controlling bacterial infections (Clatworthy et al., 2007;
Defoirdt, 2013, 2014). The inhibition of speciﬁc virulence genes
is possible (Baron, 2010). However, much more research effort
thus far has been devoted to virulence-regulatory mechanisms
because these mechanisms control the expression of (multiple)
virulence factors and consequently, by targeting these mecha-
nisms it would be possible to block several virulence factors at
once.
Host stress has long been known to inﬂuence host–pathogen
interactions. For a long time, the impact of stress on infec-
tion has been exclusively associated with the suppression of the
immune system of the host and an increased susceptibility to
infections due to elevated levels of stress hormones (Dhabhar
and McEwen, 1997; Freestone et al., 2008). However, investiga-
tions over the past decades have introduced a new perspective
which implies that infectious bacteria also respond to these stress
hormones (Lyte, 2004). The catecholamine stress hormones nore-
pinephrine (NE) and dopamine (Dopa), which are an integral
part of the ‘ﬁght or ﬂight’ stress response in animals (Reiche
et al., 2004), stimulate the growth of several species of bacteria
(including Escherichia coli, Yersinia enterocolitica, Listeria mono-
cytogenes, Aeromonas hydrophila, Pseudomonas aeruginosa, and
V. parahaemolyticus) in serum-based media (Lyte and Ernst, 1992;
Coulanges et al., 1997; Kinney et al., 1999; Belay et al., 2003;
Nakano et al., 2007a,b). Such media are iron-limited because of
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chelation of free iron by high-afﬁnity iron-binding proteins such
as transferrin. According to Sharaff and Freestone (2011), cat-
echolamines increase the availability of iron through complex
formationwith the iron-binding proteins, thereby decreasing their
afﬁnity for iron to a point of iron loss. Catecholamines have also
been reported to increase the production of Shiga toxin, chemo-
taxis, bioﬁlm formation, and attachment and colonization to
epithelial cells in pathogenic E. coli, motility and invasiveness of
Campylobacter jejuni, motility and type III secretion in Salmonella
typhimurium, and cytotoxic activity inV. parahaemolyticus (Bansal
et al., 2007; Cogan et al., 2007; Nakano et al., 2007b; Lyte et al.,
2011; Sharaff and Freestone, 2011).
Catecholamines exert their effects by binding to speciﬁc recep-
tors. In eukaryotes, epinephrine and NE bind to adrenergic
receptors, which are divided into two major families (α and β),
each with a number of receptor subtypes, while Dopa binds to
dopaminergic receptors with at least ﬁve receptor subtypes; and
binding of the hormones to the receptors can be prevented by
speciﬁc antagonists (Freestone et al., 2007). Interestingly, antag-
onists of eukaryotic adrenergic and dopaminergic receptors can
also inhibit catecholamine-induced effects in bacteria (Sharaff and
Freestone, 2011). Furthermore, several bacterial catecholamine
receptors have been reported as well, including the histidine sen-
sor kinasesQseC andQseE (Hughes et al., 2009), forwhich a highly
active antagonist, LED209, has been identiﬁed (Rasko et al., 2008).
The production of catecholamines is highly conserved in
the animal kingdom, both in vertebrates (including ﬁsh) and
invertebrates (including mollusks and crustaceans; Ottaviani and
Franceschi, 1996). However, at this moment, knowledge on the
impact of catecholamines on the virulence of major pathogens of
aquatic organisms, such as V. harveyi, is lacking. In this study, we
aimed at investigating the impact of the catecholamines NE and
Dopa on the growth of V. harveyi in serum-based medium, on
the expression of various virulence-related characteristics and on
virulence toward gnotobiotic brine shrimp (Artemia franciscana)
larvae.
MATERIALS AND METHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS
Vibrio harveyi wild type strain ATCC BAA-1116 (recently reclassi-
ﬁed as V. campbellii; Lin et al., 2010) was used in this study. Unless
otherwise stated, the strain was cultured at 28◦C in Luria broth
containing 35 g/L sodiumchloride (LB35) under constant agitation
(100min−1). Cell densitiesweremeasured spectrophotometrically
at 600 nm.
CATECHOLAMINES AND EUKARYOTIC CATECHOLAMINE RECEPTOR
ANTAGONISTS
Norepinephrinewas dissolved inhydrochloride acid (HCl 0.1N) at
10 mM,while Dopa was dissolved in distilled water at 10 mM. The
antagonists used in this study are listed in Table 1. All the chemi-
cals were purchased from Sigma–Aldrich (Bornem, Belgium). The
reagents were sterilized using a 0.22 μm ﬁlter and stored at−20◦C.
BACTERIAL GROWTH ASSAYS
For the bacterial growth assays, V. harveyi was grown overnight
in LB35 broth at 28◦C. After that, the culture was re-inoculated at
Table 1 | Catecholamine receptor antagonists used in this study.
Compound Specificity Solvent
Phentolamine hydrochloride Reversible α-adrenergic Ethanol
Phenoxybenzamine hydrochloride Irreversible α-adrenergic DMSO
S-propranolol hydrochloride β-adrenergic Ethanol
Labetalol hydrochloride α- and β-adrenergic Ethanol
Chlorpromazine hydrochloride Dopaminergic Distilled
water
LED2091 Bacterial catecholamine
receptor QseC
DMSO
All compoundswere dissolved at 10mM, except for LED209, whichwas dissolved
at 10 μM.
1N-phenyl-4-[[(phenylamino)thioxomethyl]amino]-benzenesulfonamide.
a concentration of 102 CFU/ml into fresh LB35 broth containing
30% (v/v) adult bovine serum (Sigma–Aldrich), with and with-
out 50 μM NE or Dopa. Additionally, different concentrations of
the catecholamine receptor antagonists were added in conjunction
with the catecholamines to determine whether they could neutral-
ize catecholamine-induced growth responses. The cultures were
grown in 200 μl volumes in 96-well plates at 28◦C for 48 h, and
the turbidity at 600 nm was monitored every hour using a Multi-
reader machine (Inﬁnite M200, TECAN, Austria). Growth curves
were determined for three independent cultures, and the growth
rate of the exponentially growing cultures was calculated. The sta-
tistical signiﬁcance of speciﬁc growth rate was determined using
an independent samples t-test.
SIDEROPHORE ACTIVITY ASSAY
The siderophore activity was determined by Chrome azurol S
(CAS) agar diffusion assay according to Shin et al. (2001), which
was performed as follows. The CAS agar plates were prepared
according to Schwyn and Neilands (1987); 60.5 mg (CAS; Sigma–
Aldrich) was dissolved in 50 ml deionized water, and mixed with
10 ml iron (III) solution (1 mM FeCl3·6H2O, 10 mM HCl).
Under stirring, this solution was slowly added to 72.9 mg hex-
adecyltrimethylammonium bromide (Sigma–Aldrich), dissolved
in 40 ml water. The resultant dark blue solution was autoclaved
and stored in a plastic container. Then 100 ml 10× MM9 salts,
15 g agar, 30.24 g Pipes, and 12 g of a 50% (w/v) NaOH
solution (to raise the pH to 6.8) were added to 750 ml water.
After autoclaving and cooling to 50◦C, 30 ml of a sterile 10%
casamino acids solution was added as the carbon source. The
dye solution was ﬁnally added with enough agitation to achieve
mixing without generation of foam. Serum (30%, v/v), cate-
cholamines and antagonists were added directly into the agar.
V. harveyi was cultured overnight in LB35 broth containing 30%
(v/v) serum, with or without catecholamines and antagonists.
Then the CAS agar plates were punched with 5-mm-diameter
holes and each hole was ﬁlled with 35 μl of a V. harveyi cul-
ture (OD600 = 1.0). After incubation at 28◦C for 24 h, the
size of the orange halo formed around each hole was measured.
Siderophore activity was expressed as the square value of the halo
diameter.
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SWIMMING MOTILITY ASSAY
The swimming motility assay was performed on soft agar (LB35
plates containing 0.3% agar) as described previously (Yang and
Defoirdt, 2014). The catecholamines and antagonists were added
to the autoclaved agar. V. harveyi was grown overnight in LB35
broth, and 5 μl aliquots (OD600 = 1.0) were spotted in the
center of the soft agar plates. Plates were incubated for 24 h,
after which the diameters of the motility halos were mea-
sured. All assays were done with freshly prepared media in six
replicates.
BIOFILM FORMATION ASSAY
Bioﬁlm formation assay was quantiﬁed by crystal violet stain-
ing, as described previously (Stepanovic´ et al., 2007). In brief,
an overnight culture of V. harveyi was diluted to an OD600 of
0.1 in LB35 broth with or without catecholamines and antag-
onists, and 200 μl aliquots of these suspensions were pipetted
into the wells of a 96 well plate. Then the bacteria were allowed
to adhere and grow without agitation for 24 h at 28◦C. After
that, the cultures were removed and the wells were washed three
times with 300 μl sterile physiological saline to remove all non-
adherent bacteria. The remaining attached bacteria were ﬁxed
with 150 μl of 99% methanol per well for 20 min, after which
the methanol was removed and plates were air-dried. Then,
bioﬁlms were stained for 15 min with 150 μl of a 1% crys-
tal violet solution (Pro-lab Diagnostics, Richmond Hill, ON,
Canada) per well. Excess stain was rinsed off by placing the
plate under running tap water, and washing was continued until
the washings were free of the stain. After the plates were air
dried, the dye bound to the adherent cells was resolubilized with
150 μl of 95% ethanol per well, and absorbance was measured
at 570 nm. Sterile medium served as negative control. For the
quantiﬁcation of exopolysaccharides, Calcoﬂuor white staining
(Sigma–Aldrich) was used. In brief, wells were rinsed after 24 h
bioﬁlm formation and 100 μl phosphate buffered saline contain-
ing 0.5 μl 5 mM Calcoﬂuor white staining dye was added to the
wells. After 60 min, ﬂuorescence (excitation 405 nm and emis-
sion 500 nm) was measured with a Multi-reader (Inﬁnite M200,
TECAN, Austria).
LYTIC ENZYME ACTIVITY ASSAYS
All assays were conducted according to Natrah et al. (2011). For
each assay, an overnight culture of V. harveyi was diluted to an
OD600 of 0.5 and 5 μl of the diluted culture was spotted in
the middle of the test plates. The catecholamines and antag-
onists were added to the autoclaved agar before pouring. All
assays were done at least in triplicate. Lipase and phospholi-
pase activities were assessed on marine agar plates supplemented
with 1% Tween 80 (Sigma–Aldrich) and 1% egg yolk emulsion
(Sigma–Aldrich), respectively. The development of opalescent
zones around the colonies was observed and the diameters of
the zones were measured after 2–4 days of incubation at 28◦C.
Caseinase assay plates were prepared by mixing double strength
Marine Agar with a 4% skim milk powder suspension (Oxoid,
Basingstoke, Hampshire, UK), sterilized separately at 121◦C for
5 min. Clearing zones surrounding the bacterial colonies were
measured after 2 days of incubation. Gelatinase assay plates
were prepared by mixing 0.5% gelatin (Sigma–Aldrich) into the
agar. After incubation for 7 days, saturated ammonium sul-
fate (80%) in distilled water was poured over the plates and
after 2 min, the diameters of the clearing zones around the
colonies were measured. Hemolytic assay plates were prepared
by supplementing Marine Agar with 5% deﬁbrinated sheep
blood (Oxoid) and clearing zones were measured after 2 days of
incubation.
RNA EXTRACTION
Vibrio harveyi was grown overnight in triplicate on soft agar plates
(0.3% agar). Cells were harvested and RNA was extracted with the
SV Total RNA Isolation System (Promega, Leiden, The Nether-
lands) according to the manufacturer’s instructions. The RNA
quantity was measured spectrophotometrically (NanoDrop Tech-
nologies, Wilmington, DE, USA) and adjusted to 200 ng μl−1
in all samples. The RNA integrity was checked by Agarose Gel
Electrophoresis and the RNA samples were stored in −80◦C for
subsequent use.
PRIMERS
Speciﬁc primers were used for 10 selected genes involved in motil-
ity of V. harveyi (Yang and Defoirdt, 2014). The RNA polymerase
A submit (rpoA) mRNA was used as an endogenous control
(Defoirdt et al., 2007).
REVERSE TRANSCRIPTION
Reverse transcription was performed with the RevertAidTM H
minus First strand cDNA synthesis kit (Fermentas Gmbh, Baden-
Württemberg, Germany) in accordance to the manufacturer’s
instructions. Brieﬂy, a mixture of 1 μg RNA and 1 μl random
hexamer primer solution was mixed ﬁrst. Then, 8 μl of reaction
mixture containing 4 μl of 5× reaction buffer (0.25 mol−1 Tris-
HCl pH 8.3, 0.25 mol−1 KCl, 0.02 mol−1 MgCl2, 0.05 mol−1
DTT), 2 μl of 0.01 mol−1 dNTP mix, 20 units of ribonuclease
inhibitor, 200 units of RevertAidTM H minus M-MuLV Reverse
Transcriptase was added. The reaction mixture was incubated for
5 min at 25◦C followed by 60 min at 42◦C. The reaction was ter-
minated by heating at 70◦C for 5 min and then cooled to 4◦C.
cDNA samples were checked by PCR and stored at −20◦C for
further use.
REAL-TIME PCR
Real-time PCR was used to quantify the expression level of
all the ﬂagella-related genes and was performed with Maxima®
SYBR Green/ROX qPCR Master Mix (Fermentas, Fisher Scien-
tiﬁc, Erembodegem, Belgium) as described previously (Yang and
Defoirdt, 2014). The reaction was performed in an StepOneTM
Real-Time PCR System thermal cycler (Applied Biosystems, Gent,
Belgium) in a total volume of 25 μl, containing 12.5 μl of
2× SYBR green master mix, 300 nM of forward and reverse
primers and 2 μl of template cDNA. The thermal cycling con-
sisted an initial denaturation at 95◦C for 10 min followed by
40 cycles of denaturation at 95◦C for 15 s and primer annealing
and elongation at 60◦C for 1 min. Dissociation curve analy-
sis was performed to check for the ampliﬁcation of untargeted
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fragments. Data acquisition was performed with the StepOneTM
Software.
REAL-TIME PCR DATA ANALYSIS (2–Ct METHOD)
The real-time PCR was validated by amplifying serial dilutions
of cDNA synthesized from 1 μg of RNA isolated from bacterial
samples. Serial dilutions of cDNA were ampliﬁed by real time
PCR using gene speciﬁc primers. Ct (average Ct value of target–
average Ct value of rpoA) was calculated for the different dilutions
and plotted against the cDNA concentration. The slope of the
graph was almost equal to 0 for all of the target nine genes. There-
fore, the ampliﬁcation efﬁciency of reference and the target genes
was considered to be equal. Based on this precondition, real-time
PCR data were analyzed using the 2−Ct method (Schmittgen
and Livak, 2008). The expression of the target genes was normal-
ized to the endogenous control (rpoA) by calculating Ct:
Ct = Ct target − Ct rpoA
and expressed relative to a calibrator strain by calculating Ct:
Ct = Ct − Ct calibratior
Strain BB120 without any treatments was used as acalibrator. The
relative expression was then calculated as
Relative expression = 2−Ct
AXENIC HATCHING OF BRINE SHRIMP LARVAE
Two hundred milligrams of high-quality hatching cysts of Artemia
franciscana (EG® Type; INVE Aquaculture, Baasrode, Belgium)
were hydrated in 18 ml of ﬁltersterilized tap water for 1 h. Ster-
ile cysts were obtained by decapsulation based on the method
described by Marques et al. (2004). Brieﬂy, 660 μl of NaOH (32%)
and 10 ml of NaOCl (50%) were added to the hydrated cyst sus-
pension to facilitate decapsulation. The process was stopped after
2 min by adding 14 ml of Na2S2O3 (10 g L−1). Filtered (0.22 μm)
aeration was provided during the reaction. The decapsulated cysts
were washed with ﬁltered (passed through 0.22-μm membrane
ﬁlter) and autoclaved (moist heat at 121◦C for 15 min) artiﬁcle
seawater (containing 35 g l−1 of instant ocean synthetic sea salt,
Aquarium Systems, Sarrebourg, France). The cysts were resus-
pended in a 50-ml tube containing 30 ml of ﬁltered, autoclaved
seawater and hatched for 28 h on a rotor (4 min−1) at 28◦C with
constant illumination (c. 2000 lux). The axenity of cysts was ver-
iﬁed by inoculating one ml of culture water into 9 ml of Marine
broth and incubating at 28◦C for 24 h. After 28 h of hatching,
batches of 30 larvae were counted and transferred to fresh, sterile
50-ml tubes containing 30 ml of ﬁltered and autoclaved seawater.
Finally, the tubes were returned to the rotor and kept at 28◦C.
All manipulations were performed in a laminar ﬂow to maintain
sterility of the cysts and larvae.
BRINE SHRIMP CHALLENGE TEST
The effects of the catecholamines and antagonists on the virulence
of V. harveyi were determined in a standardized challenge test with
gnotobiotic brine shrimp larvae. V. harveyi was incubated with or
without NE or Dopa (50 μM) and with or without antagonists,
and cultures were washed with phosphate-buffered saline (pH 7.4)
prior to inoculation into the brine shrimp rearingwater at 105 CFU
ml−1. The challenge tests were performed as described by Defoirdt
et al. (2005) with some modiﬁcations. A suspension of autoclaved
LVS3 bacteria (Verschuere et al., 1999) in ﬁltered and autoclaved
seawater was added as feed at the start of the challenge test at
107 cells ml−1 culture water. Brine shrimp cultures to which only
autoclaved LVS3 bacteriawere added as feed,were used as controls.
The survival of the larvaewas counted 48 h after the addition of the
pathogens. Each treatment was carried out in quadruplicate and
each experiment was repeated twice to verify the reproducibility.
In each test, the sterility of the control treatments were checked
at the end of the challenge by inoculating 1 ml of rearing water
to 9 ml of Marine Broth and incubating the mixture for 2 days
at 28◦C.
STATISTICAL ANALYSES
Data analysis was carried out using the SPSS statistical software
(version 15). Log transformed gene expression data were analysed
using independent samples t-tests. Unless stated otherwise, all
other data were compared with one-way ANOVA, followed by
Tukey’s post hoc test.
RESULTS
EFFECTS OF CATECHOLAMINES AND ANTAGONISTS ON THE
SWIMMING MOTILITY OF V. harveyi
Motility is required for the virulence of V. harveyi (Yang and
Defoirdt, 2014), and since catecholamines are known to affect
the motility of other pathogens (Lyte et al., 2011) we investi-
gated the effect of catecholamines on the swimming motility of
V. harveyi on soft agar. Both NE and Dopa could signiﬁcantly
increase the swimming motility of V. harveyi (Figures 1 and 2).
We investigated the effects of catecholamines on the expression
of ten selected genes involved in ﬂagellar motility in V. harveyi,
including six genes involved in the synthesis of the polar ﬂagellum
(both regulators and structural genes), two genes involved in the
synthesis of lateral ﬂagella, and two genes involved in chemotaxis.
Both NE and Dopa signiﬁcantly up-regulated the expressions of
all selected genes (Table 2) which conﬁrmed the stimulatory effect
of catecholamines on ﬂagellar motility.
We further evaluated whether catecholamine receptor antago-
nists could neutralize catecholamine-induced swimming motility.
The α-adrenergic antagonists phentolamine and phenoxybenza-
mine, theα-andβ-adrenergic antagonist labetalol and the bacterial
catecholamine receptor antagonist LED209 could neutralize NE-
induced swimming motility (Figure 1), whereas the non-selective
β-adrenergic receptor antagonist propranolol and the dopaminer-
gic antagonist chlorpromazine had no effect (data not shown).
Further, the dopaminergic antagonist chlorpromazine and the
bacterial catecholamine receptor antagonist LED209 neutralized
Dopa-induced motility (Figure 2), whereas adrenergic recep-
tor antagonists had no effect (data not shown). Finally, we also
checked the swimming motility of bacteria in the presence of only
antagonists and equivalent volumes of the solvents as used in com-
bination with the catecholamines, and no effects were observed
(data not shown).
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FIGURE 1 | Impact of norepinephrine (NE) and NE receptor antagonists on swimming motility ofV. harveyi. The error bars indicate the SD of six replicate
cultures. Different letters indicate signiﬁcant differences (One way ANOVA with Tukey’s post hoc test; p < 0.01). (A) NE with and without phentolamine, (B) NE
with and without phenoxybenzamine, (C) NE with and without labetalol, (D) NE with and without propanolol and (E) NE with and without LED209.
EFFECTS OF CATECHOLAMINES AND ANTAGONISTS ON THE GROWTH
OF V. harveyi IN SERUM-SUPPLEMENTED MEDIUM
The addition of NE or Dopa increased the growth of V. harveyi in
Marine Broth containing 30% (v/v) serum (Figure 3) and resulted
in a 2.4- and 2.1-fold increase in the growth rate of V. harveyi,
respectively (0.59 ± 0.05 h−1 and 0.53 ± 0.04 h−1 in the presence
of NE and Dopa, respectively, compared to 0.25 ± 0.03 h−1 for
the untreated control). When compared to untreated cultures,
the maximum turbidity was 1.6-fold higher for both NE and
Dopa supplemented cultures. The catecholamines had no effect on
growth of V. harveyi in medium without serum (data not shown).
In further experiments, we investigated whether catecholamine
receptor antagonists could neutralize the growth-stimulatory
effects of the catecholamines in serum-supplemented LB35
broth containing 50 μM catecholamines. The results were
consistent with what we observed in the motility assays: antag-
onists with α-adrenergic activity (but not antagonists with only
β-adrenergic activity) were able to inhibit NE-induced growth
(Figure 3A), and the adrenergic antagonists were not able
to neutralize Dopa-induced growth (data not shown). Fur-
ther, the dopaminergic antagonist chlorpromazine neutralized
Dopa-induced growth but had no effect on NE-induced growth
(Figure 3B). The prokaryotic catecholamine receptor antagonist
LED209 was able to neutralize the effects of both NE and Dopa.
None of the antagonists and solvents used to dissolve the antag-
onists affected the growth of V. harveyi when tested alone at the
same volumes as used in combination with catecholamines (data
not shown), which indicates that the growth inhibition by the
antagonists was not due to toxicity, but a speciﬁc antagonism of
the bacterial response to catecholamines.
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Table 2 | Impact of catecholamines on the expression of flagellar motility-related genes inV. harveyi.
Gene Function Relative expression (fold)1
Untreated Norepinephrine (NE) (50 μM) Dopamine (Dopa) (50 μM)
ﬂaA Polar ﬂagellin 1.0 ± 0.1 2.8 ± 0.4** 1.6 ± 0.1**
ﬂaC Polar ﬂagellin 1.0 ± 0.1 1.9 ± 0.1*** 1.3 ± 0.2*
ﬂaK Polar ﬂagellar regulator 1.0 ± 0.3 2.9 ± 0.2*** 1.7 ± 0.3**
ﬂiA Polar ﬂagellar biosynthesis sigma factor 1.0 ± 0.4 2.9 ± 0.5** 2.2 ± 0.1***
ﬂiS Polar ﬂagellin speciﬁc chaperone 1.0 ± 0.3 3.2 ± 0.5** 1.7 ± 0.1***
ﬂgB Flagellar basal body rod 1.0 ± 0.2 3.2 ± 0.3** 1.4 ± 0.4**
cheA Chemotaxis protein 1.0 ± 0.1 2.5 ± 0.3*** 1.9 ± 0.2**
cheR Chemotaxis protein 1.0 ± 0.4 2.0 ± 0.1** 1.4 ± 0.3*
lafA Lateral ﬂagellar ﬂagellin 1.0 ± 0.3 3.0 ± 0.4** 1.9 ± 0.1***
lafK Lateral ﬂagellar regulator 1.0 ± 0.2 3.0 ± 0.6** 1.6 ± 0.4**
1For each gene, the expression in untreated cultures was set at 1 and the expression in cultures supplemented with catecholamines was normalized accordingly
using the 2−Ct method. Data are average ± SD of three V. harveyi cultures. Asterisks indicate a signiﬁcant difference when compared to untreated V. harveyi
(independent samples t-test; *p < 0.05; **p < 0.01; ***p < 0.001).
EFFECTS OF CATECHOLAMINES AND ANTAGONISTS ON SIDEROPHORE
PRODUCTION
In order to further substantiate the link between iron availability
and growth induction by catecholamines in serum-supplemented
medium, we determined the impact of the catecholamines
on siderophore production. Both NE and Dopa signiﬁcantly
increased the siderophore production of V. harveyi, and the
effect could be neutralized by phentolamine and chlorpromazine
at a concentration of 100 and 10 μM, respectively (Figure 4).
This is consistent with the antagonist concentrations needed to
neutralize the growth-inducing effect of the catecholamines in
serum-supplemented medium.
EFFECTS OF CATECHOLAMINES AND ANTAGONISTS ON BIOFILM
FORMATION AND EXOPOLYSACCHARIDE PRODUCTION
Bioﬁlm formation of V. harveyi was determined by crystal violet
staining. The catecholamines signiﬁcantly increased bioﬁlm for-
mation, and the effect was blocked by the antagonists (Figure 5).
Because exopolysaccharide production is one of the major fac-
tors affecting bioﬁlm formation, we also determined the impact
FIGURE 2 | Impact of dopamine (Dopa) and Dopa receptor antagonists on swimming motility ofV. harveyi.The error bars indicate the SD of six replicate
cultures. Different letters indicate signiﬁcant differences (One way ANOVA withTukey’s post hoc test; p < 0.01). (A) Dopa with and without chlorpromazine and
(B) Dopa with and without LED209.
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FIGURE 3 | Impact of catecholamines and catecholamine receptor
antagonists on the growth ofV. harveyi in LB35 broth containing 30%
(v/v) serum. (A) NE and adrenergic antagonists. (B) Dopa and
dopaminergic antagonists. The initial density of V. harveyi was 102 CFU/ml.
Error bars represent the SD of three independent cultures.
of the catecholamines on exopolysaccharide production by Cal-
coﬂuor white staining. The catecholamines signiﬁcantly increased
exopolysaccharide production (2.5- and 2.0-fold increase in the
presence of NE and Dopa, respectively), and this could be
neutralized by the antagonists (Figure 6). Importantly, the antag-
onists and solvents showed no inﬂuence on bioﬁlm formation or
exopolysaccharide production in the absence of catecholamines
(data not shown).
EFFECTS OF CATECHOLAMINES AND ANTAGONIST ON OTHER
VIRULENCE FACTORS
The impacts of catecholamines on ﬁve other virulence factors
(lipase, phospholipase, gelatinase, hemolysin, and caseinase pro-
duction) were determined as well. NE and Dopa slightly decreased
FIGURE 4 | Impact of catecholamines and catecholamine receptor
antagonists on siderophore production by V. harveyi. The
concentration of catecholamines used is 50 μM. Phentolamine and
chlorpromazine was added at a concentration of 100 and 10 μM,
respectively. The error bars indicate the SD of six replicate cultures.
Different letters indicate signiﬁcant differences (One way ANOVA with
Tukey’s post hoc test; p < 0.01).
gelatinase activity (1.2- and 1.1-fold, respectively), while there
was no signiﬁcant effect on caseinase, lipase, phospholipase, or
hemolytic activity (data not shown).
EFFECTS OF CATECHOLAMINES AND ANTAGONIST ON THE VIRULENCE
OF V. harveyi TOWARD BRINE SHRIMP LARVAE
In vitro experiments revealed that the catecholamines NE and
Dopa positively regulated virulence-related phenotypes in V. har-
veyi, including growth in an iron-limited environment, swimming
motility, bioﬁlm formation, and exopolysaccharide production.
To examine whether this results in an increased virulence of
the bacterium in vivo, we performed a standardized challenge
test with gnotobiotic brine shrimp larvae. In order to exclude
any direct effects of the catecholamines on the host, V. har-
veyi was pretreated with the hormones for 4 h, after which
the pathogen was washed with phosphate-buffered saline and
then inoculated into the brine shrimp rearing water. Signiﬁ-
cantly higher brine shrimp mortality rates were observed when
exposing V. harveyi to NE or Dopa prior to the challenge
(Table 3).
We further evaluated the effects of catecholamine antag-
onists by pretreating V. harveyi with both catecholamines
and antagonists. The α-adrenergic antagonists phentolamine
and phenoxybenzamine, the α- and β-adrenergic antagonist
labetalol and the prokaryotic catecholamine receptor antagonist
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FIGURE 5 | Impact of catecholamines and catecholamine receptor
antagonists on biofilm formation by V. harveyi. (A) NE and adrenergic
antagonists. (B) Dopa and dopaminergic antagonists. The error bars
represent SD of three independent experiments. Different letters indicate
signiﬁcant differences (One way ANOVA with Tukey’s post hoc test;
p < 0.01).
FIGURE 6 | Impact of catecholamines and catecholamine receptor
antagonists on exopolysaccharide production ofV. harveyi. (A) NE and
adrenergic antagonists. (B) Dopa and dopaminergic antagonists. The error
bars represent SD of three independent experiments. Different letters
indicate signiﬁcant differences (One way ANOVA with Tukey’s post hoc test;
p < 0.01).
LED209 were all able to neutralize the increased virulence
induced by NE, whereas the dopaminergic antagonist chlorpro-
mazine and LED209 neutralized the effect of Dopa (Table 3).
Pretreatment of V. harveyi with the antagonists had no effect
on virulence in the absence of catecholamines (data not
shown).
DISCUSSION
The successful interaction between bacteria and their host depends
not only on a coordinated response to population density, temper-
ature and pH (Mekalanos, 1992; Winzer and Williams, 2001), but
also on the detection of diverse host cell effector molecules such
as catecholamine stress hormones (Burton et al., 2002). Exposure
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Table 3 | Impact of pretreatment ofV. harveyi with catecholamines
and catecholamine receptor antagonists on virulence of the
bacterium toward gnotobiotic brine shrimp larvae.
Treatment Survival (%)a
Control 100 ± 0c
V. harveyi 50 ± 5b
V. harveyi [50 μM NE] 27 ± 6a
V. harveyi [50 μM NE + 100 μM phentolamine] 48 ± 3b
V. harveyi [50 μM NE + 10 μM phenoxybenzamine] 47 ± 3b
V. harveyi [50 μM NE + 50 μM labetalol] 48 ± 3b
V. harveyi [50 μM NE + 100 μM propanolol] 29 ± 4a
V. harveyi [50 μM NE + 5 pM LED209] 55 ± 5b
V. harveyi [50 μM Dopa] 35 ± 5a
V. harveyi [50 μM Dopa + 50 μM chlorpromazine] 47 ± 3b
V. harveyi [50 μM Dopa + 5 pM LED209] 52 ± 8b
aSurvival after 2 days of challengewithV. harveyi ATCCBAA-1116 (average± SE of
four replicates). Survival in the control treatment was set at 100% and the other
treatments were normalized accordingly. Square brackets refer to pretreatment –
V. harveyi was either or not pretreated with catecholamines and antagonists for
4 h and washed prior to inoculation into the brine shrimp rearing water. Values
with a different superscript letter are signiﬁcantly different from each other (One
way ANOVA with Tukey’s post hoc test; p < 0.01).
of bacteria to catecholamine stress hormones has been demon-
strated to stimulate both growth and production of virulence-
related factors in various pathogens of terrestrial animals and
humans, such as E. coli (Bansal et al., 2007), C. jejuni (Cogan
et al., 2007), S. typhimurium (Bearson and Bearson, 2008), and
V. parahaemolyticus (Nakano et al., 2007b). The present study
demonstrates that the catecholamines NE and Dopa could sig-
niﬁcantly increase the production of major virulence factors and
growth in serum-supplemented medium of V. harveyi, a major
pathogen of aquatic organisms with a broad host spectrum (both
vertebrates such as ﬁsh and invertebrates such as crustaceans and
mollusks). This result is in good agreement with, and considerably
extends, the previous reports.
The catecholamines signiﬁcantly increased the virulence of
V. harveyi toward gnotobiotic brine shrimp larvae. The pathogen
was pretreated with catecholamines in order to avoid a direct
effect of catecholamines on the host (e.g., decreased activity of
the defense system) and to ensure that any impact on survival of
challenged larvae was due to increased virulence of the pathogen.
This is further substantiated by our observation that in addi-
tion to their effect on growth in serum-supplemented medium
and siderophore production, the catecholamines increased the
production of several other phenotypes that are important for
infection. Indeed, both NE and Dopa signiﬁcantly stimulated
bioﬁlm formation, exopolysaccharide production, swimming
motility, and the expression of genes involved in ﬂagellum syn-
thesis (structural genes and regulators including the ﬂagellar
master regulator) in V. harveyi. These results agree well with
previous reports documenting the impact of catecholamines
on bioﬁlm formation in Staphylococcus epidermidis (Lyte et al.,
2003) and on swimming motility in E. coli, C. jejuni, and
Edwardsiella tarda (Cogan et al., 2007; Kendall et al., 2007;
Wang et al., 2011).
Catecholamines are produced by hemocytes of invertebrates,
and concentrations in the hemolymph of shrimp and prawn
that have been reported range between 10 and ∼3 μM (Chen
et al., 2003; Hsieh et al., 2006; Pan et al., 2014). These concen-
trations are lower than the concentrations used in this study.
However, local concentrations can be considerably higher. For
instance, the intrasynaptic concentration of NE in the cen-
tral nervous system of mammals is as high as 10 mM (ver-
sus nM levels in serum; Lyte, 2004). Hence, upon infection,
pathogens can come into contact with local concentrations
that are several orders of magnitude higher than those that
are found in hemolymph (or serum in case of vertebrates).
This probably is also the case when tissues and/or hemo-
cytes are damaged during infection and hence, elevated cate-
cholamine levels might be a cue informing the pathogen of tissue
damage.
Pretreatment of V. harveyi with catecholamines simulated
transmission of the pathogen from a host site showing ele-
vated catecholamine levels (e.g., due to cell or tissue damage).
In combination with our observation that the catecholamines
increased bioﬁlm formation, exopolysaccharide production, and
swimming motility of V. harveyi (which are all important dur-
ing the initial stages of infection), our results suggest that
catecholamine sensing increases the success of transmission to
a new host. Hence, elevated catecholamine levels might be a
cue informing the pathogen that the infection reached a ﬁnal
stage (cell and tissue damage) and that it is time to leave the
host.
Catecholamine receptor antagonists have been used exten-
sively to identify and characterize catecholamine receptors in
mammals. The effects of various antagonists on growth and
production of virulence factors in V. harveyi have been inves-
tigated in the present study, and the results demonstrated
that α- but not β-adrenergic receptor antagonists could block
responses to NE, but did not show any effect on Dopa respon-
siveness. On the contrary, dopaminergic receptor antagonists
neutralized induction caused by Dopa, but did not neutral-
ize induction by NE. Similar results have been reported in
enteric pathogens of terrestrial animals (Freestone et al., 2007),
and suggest that bacterial response systems for catecholamines
possess a degree of speciﬁcity similar to mammalian cate-
cholamine receptors. In contrast to the wealth of adrenergic
and dopaminergic receptors described in eukaryotes, there have
been only few reports examining the presence of such recep-
tors in bacteria. Clarke et al. (2006) reported that NE was able
to be recognized by the E. coli O157:H7 two-component reg-
ulator sensor kinase QseC in in vitro constructs, leading to
the hypothesis that this is the bacterial catecholamine receptor.
Later on, a QseC antagonist, LED209, has been identiﬁed in
a high-throughput screen (Rasko et al., 2008). We found that
LED209 was able to neutralize the effects of both NE and Dopa,
indicating that a similar response system for catecholamines
might exist in V. harveyi. This is also substantiated by the fact
that the V. harveyi ATCC BAA-1116 genome contains a QseC
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homolog. Alternatively, since our experiments with eukaryotic
catecholamine receptor antagonists showed that dopaminergic
antagonists did not neutralize NE-induced effects and vice versa,
there are probably at least two different catecholamine recep-
tors in V. harveyi, with LED209 being able to bind to both of
them. Further research will be needed in order to identify the
catecholamine receptors and the signal transduction pathways in
V. harveyi.
Both NE and Dopa signiﬁcantly stimulated the growth of
V. harveyi in serum-supplemented medium, and this effect could
be neutralized by eukaryotic catecholamine receptor antagonists.
Similar results have been reported in other Gram-negative bacte-
ria such as E. coli and V. parahaemolyticus, and the stimulation of
growth in serum-supplemented medium by catecholamines has
mainly been attributed to their ability to facilitate iron removal
from the host iron-binding proteins transferrin and lactoferrin
(Lyte, 2004; Nakano et al., 2007b). We used bovine serum since
it was practically not feasible to obtain sufﬁcient amounts of
crustacean serum. However, it should be noted that crustaceans
produce equivalents of iron-binding proteins produced by mam-
mals (e.g., Toe et al., 2012). Our observations that catecholamine
receptor antagonists are able to neutralize the growth-stimulatory
effect of catecholamines and that adrenergic receptor antago-
nists were found to show no effect on Dopa-induced growth
and vice versa suggest that a regulatory mechanism involving
catecholamine receptors is involved as well, and this has also
been reported for enteric pathogens such as E. coli O157:H7,
S. enterica and Y. enterocolitica (Freestone et al., 2007). To con-
ﬁrm the hypothesis that in addition to increasing iron uptake
in a direct way, catecholamines induced an iron uptake mecha-
nism, we investigated the effect of catecholamines on siderophore
production, and found that both NE and Dopa could signiﬁ-
cantly induce siderophore production. Siderophores have been
reported to be essential for catecholamine-induced growth in
other Gram-negative bacteria such as E. coli and Salmonella,
where they serve to internalize the iron removed by the cate-
cholamines (Freestone et al., 2003; Williams et al., 2006). Finally,
it should be noted that in addition to limiting iron availability,
serum might have other effects on the pathogens as well. Serum,
e.g., contains proteins (some of which might have antimicro-
bial activity; Zasloff, 2002). However, in view of the literature
that is available on other pathogens and our observation that
catecholamines increase siderophore production we think that
modulation of iron availability is the most plausible explana-
tion of growth stimulation by catecholamines in the presence of
serum.
CONCLUSION
Our study has shown that the catecholamines NE and Dopa
increase the virulence of V. harveyi by increasing swimming motil-
ity, bioﬁlm formation, exopolysaccharide production, and growth
in environments with low iron availability, and the effects could
be neutralized by antagonists for eukaryotic catecholamine recep-
tors and the bacterial catecholamine receptor antagonist LED209.
Different effects of the adrenergic and dopaminergic receptor
antagonists indicate the presence of speciﬁc sensing systems for
different catecholamines in V. harveyi.
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